Phil, a pharmacist on social video, takes on the question of whether GLP-1 drugs work better alongside hormone replacement therapy.
Recap by typeshit. Video by @philsmypharmacist on TikTok.
He says close to 40% of weight lost in the trial's body-scan group was lean mass, and argues muscle loss isn't the drug's fault.
Wayne Pratt walks through what happens in the brain when drugs like Ozempic dial down the constant background chatter about eating.
Bikman cites a trial where people who lost about 21% and switched to placebo regained 14% within a year, while those who stayed on kept losing.
In Genome Medicine, diet-triggered delivery beat constant secretion on fat and liver fat, and kept down gut microbes carrying GLP-1-degrading peptidase genes.
Christoffer Røst Benneballe of Nordea argues Novo Nordisk needs the Wegovy pill as fresh pipeline growth while Eli Lilly's competition heats up.
Novo also reported 25% average weight loss in women on CagriSema in a post-hoc trial analysis, while BMO flagged Ozempic losing US share.
Loading…